News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
287,392 Results
Type
Article (22202)
Company Profile (133)
Press Release (265046)
Multimedia
Podcasts (57)
Webinars (19)
Section
Business (84209)
Career Advice (843)
Deals (13498)
Drug Delivery (87)
Drug Development (28149)
Employer Resources (147)
FDA (5443)
Job Trends (7024)
News (132337)
Policy (10587)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1606)
Academic (2)
Accelerated approval (17)
Adcomms (17)
Allergies (60)
Alliances (24950)
ALS (80)
Alzheimer's disease (874)
Antibody-drug conjugate (ADC) (267)
Approvals (5683)
Artificial intelligence (396)
Autoimmune disease (132)
Automation (33)
Bankruptcy (71)
Best Places to Work (5649)
BIOSECURE Act (13)
Biosimilars (127)
Biotechnology (84)
Bladder cancer (89)
Brain cancer (27)
Breast cancer (326)
Cancer (2556)
Cardiovascular disease (214)
Career advice (764)
Career pathing (40)
CAR-T (181)
CDC (26)
Cell therapy (451)
Cervical cancer (18)
Clinical research (24114)
Collaboration (1288)
Compensation (273)
Complete response letters (27)
COVID-19 (1255)
CRISPR (66)
C-suite (677)
Cystic fibrosis (68)
Data (3377)
Decentralized trials (2)
Denatured (25)
Depression (66)
Dermatology (34)
Diabetes (235)
Diagnostics (3378)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (38)
Drug discovery (210)
Drug pricing (66)
Drug shortages (5)
Duchenne muscular dystrophy (132)
Earnings (25065)
Editorial (26)
Employer branding (23)
Employer resources (124)
Events (41682)
Executive appointments (679)
FDA (7018)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (9)
Funding (1017)
Gene editing (130)
Generative AI (39)
Gene therapy (308)
GLP-1 (510)
Government (1643)
Grass and pollen (1)
Guidances (178)
Healthcare (6588)
HIV (44)
Huntington's disease (28)
IgA nephropathy (41)
Immunology and inflammation (94)
Immuno-oncology (41)
Indications (64)
Infectious disease (1415)
Inflammatory bowel disease (118)
Inflation Reduction Act (9)
Influenza (70)
Intellectual property (131)
Interviews (119)
IPO (5451)
IRA (17)
Job creations (1538)
Job search strategy (647)
JPM (36)
Kidney cancer (6)
Labor market (88)
Layoffs (233)
Leadership (22)
Legal (2096)
Liver cancer (52)
Longevity (16)
Lung cancer (346)
Lymphoma (221)
Machine learning (31)
Management (43)
Manufacturing (529)
MASH (57)
Medical device (4176)
Medtech (4208)
Mergers & acquisitions (8689)
Metabolic disorders (621)
mRNA (82)
Multiple sclerosis (103)
NASH (10)
Neurodegenerative disease (188)
Neuropsychiatric disorders (37)
Neuroscience (1552)
Neurotech (1)
NextGen: Class of 2026 (2427)
Non-profit (1780)
Now hiring (73)
Obesity (322)
Opinion (147)
Ovarian cancer (80)
Pain (109)
Pancreatic cancer (99)
Parkinson's disease (169)
Partnered (24)
Patents (236)
Patient recruitment (262)
Peanut (18)
People (32127)
Pharmaceutical (26)
Pharmacy benefit managers (7)
Phase 1 (7465)
Phase 2 (10208)
Phase 3 (8815)
Pipeline (3465)
Policy (119)
Postmarket research (779)
Preclinical (3688)
Press Release (62)
Prostate cancer (112)
Psychedelics (27)
Radiopharmaceuticals (137)
Rare diseases (406)
Real estate (3041)
Recruiting (59)
Regulatory (8919)
Reports (53)
Research institute (1430)
Resumes & cover letters (109)
Rett syndrome (8)
RNA editing (14)
RSV (50)
Schizophrenia (84)
Series A (201)
Series B (131)
Service/supplier (7)
Sickle cell disease (49)
Special edition (13)
Spinal muscular atrophy (71)
Sponsored (20)
Startups (2314)
State (1)
Stomach cancer (8)
Supply chain (54)
Tariffs (22)
The Weekly (31)
Vaccines (462)
Venture capital (82)
Weight loss (195)
Women's health (54)
Worklife (19)
Date
Last 7 days (328)
Last 30 days (1249)
Last 365 days (14394)
2026 (4006)
2025 (14195)
2024 (15959)
2023 (18009)
2022 (23932)
2021 (26128)
2020 (23352)
2019 (18787)
2018 (13862)
2017 (13775)
2016 (13206)
2015 (14774)
2014 (10826)
2013 (9274)
2012 (9743)
2011 (10044)
2010 (9396)
Location
Africa (397)
Alabama (42)
Alaska (4)
Arizona (121)
Arkansas (6)
Asia (30514)
Australia (4039)
California (5413)
Canada (1649)
China (819)
Colorado (212)
Connecticut (171)
Delaware (215)
Europe (41671)
Florida (751)
Georgia (139)
Hawaii (3)
Idaho (17)
Illinois (318)
India (64)
Indiana (330)
Iowa (12)
Japan (407)
Kansas (95)
Kentucky (16)
Louisiana (14)
Maine (13)
Maryland (612)
Massachusetts (4125)
Michigan (166)
Minnesota (234)
Mississippi (5)
Missouri (59)
Montana (9)
Nebraska (12)
Nevada (40)
New Hampshire (25)
New Jersey (1572)
New Mexico (20)
New York (1606)
North Carolina (707)
North Dakota (9)
Northern California (2837)
Ohio (195)
Oklahoma (12)
Oregon (22)
Pennsylvania (766)
Puerto Rico (9)
Rhode Island (19)
South America (480)
South Carolina (15)
Southern California (1919)
Tennessee (86)
Texas (809)
United States (19011)
Utah (116)
Vermont (1)
Virginia (149)
Washington D.C. (37)
Washington State (411)
West Virginia (1)
Wisconsin (101)
Wyoming (1)
287,392 Results for "nextgen sciences ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Alzheimer’s disease
4 Next-Gen Candidates That Could Form the Future of Alzheimer’s Treatment
Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting gene silencers to blood-brain barrier delivery platforms—is entering the pipeline to anchor future combination therapies.
January 19, 2026
·
7 min read
·
Ben Hargreaves
NextGen
Trace Unites ALS Teams Behind a Target That Could Broaden Treatment Access
Trace Neuroscience, a member of
BioSpace
’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims to bring more treatment options to the ALS community.
March 25, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
BioMark Aligns with National Strategy to Slash Lung Cancer Mortality with Next-Gen Liquid Biopsy
Next-generation metabolomics and AI technology supports the 2026 - 2035 Pan-Canadian Lung Cancer Action Plan’s call to expand equitable access to life-saving early diagnosis
November 12, 2025
·
3 min read
Press Releases
NeXtGen Biologics Successfully Completes First FDA Audit with Zero 483 Observations
October 28, 2025
·
1 min read
Press Releases
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
March 10, 2026
·
9 min read
Podcast
Prasad’s Leaked FDA Memo, Alzheimer’s Ups and Downs, Next-Gen Obesity Drugs
Experts unpack the implications of CBER Director Vinay Prasad’s claim that COVID vaccines have caused 10+ child deaths; the 2025 Clinical Trials on Alzheimer’s Disease conference continues following two disappointing readouts; and Novo Nordisk’s amycretin yields promising weight loss results.
December 3, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Faron Pharmaceuticals Ltd: Director Dealing
March 19, 2026
·
3 min read
Press Releases
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
April 1, 2026
·
10 min read
NextGen
Rising Amid Flurry of CAR T Deals, Stylus Proves Cell Therapy Is Not Dead
Stylus Medicine, a member of
BioSpace
’s NextGen Class of 2026, launched in May 2025 to develop new, less complex genetic medicines. The company’s in vivo approach has attracted “intense” interest from Big Pharma.
March 10, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Cell and Gene Therapy Quality Control and Analytics Market Accelerates as AI, Advanced Testing, and Global Partnerships Drive Next-Gen Therapeutics
December 9, 2025
·
1 min read
Previous
2 of 28,740
Next
